|
1
|
Mengoli MC, Longo FR, Fraggetta F, Cavazza
A, Dubini A, Ali G, Guddo F, Gilioli E, Bogina G, Nannini N, et al:
The 2015 world health organization classification of lung tumors:
New entities since the 2004 classification. Pathologica. 110:39–67.
2018.PubMed/NCBI
|
|
2
|
Mignard X, Ruppert AM, Antoine M, Vasseur
J, Girard N, Mazières J, Moro-Sibilot D, Fallet V, Rabbe N,
Thivolet-Bejui F, et al: c-MET overexpression as a poor predictor
of MET amplifications or exon 14 mutations in lung sarcomatoid
carcinomas. J Thorac Oncol. 13:1962–1967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ali G, Bruno R, Poma AM, Affinito O,
Monticelli A, Piaggi P, Ricciardi S, Lucchi M, Melfi F, Chella A,
et al: Whole transcriptome targeted gene quantification provides
new insights on pulmonary sarcomatoid carcinomas. Sci Rep.
9:35362019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roesel C, Kambartel K, Kopeika U, Berzins
A, Voshaar T and Krbek T: Lazarus-type tumour response to therapy
with nivolumab for sarcomatoid carcinomas of the lung. Curr Oncol.
26:e270–e273. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manzotti G, Torricelli F, Benedetta D,
Lococo F, Sancisi V, Rossi G, Piana S and Ciarrocchi A: An
epithelial-to-mesenchymal transcriptional switch triggers evolution
of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib
as new therapeutic option. Clin Cancer Res. 25:2348–2360. 2019.
View Article : Google Scholar
|
|
6
|
Tamaki T, Shimizu T, Niki M, Shimizu M,
Nishizawa T and Nomura S: Immunohistochemical analysis of NANOG
expression and epithelial-mesenchymal transition in pulmonary
sarcomatoid carcinoma. Oncol Lett. 13:3695–3702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aiello NM and Kang Y: Context-dependent
EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Campbell K: Contribution of
epithelial-mesenchymal transitions to organogenesis and cancer
metastasis. Curr Opin Cell Biol. 55:30–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Staalduinen J, Baker D, Ten Dijke P
and van Dam H: Epithelial-mesenchymal-transition-inducing
transcription factors: New targets for tackling chemoresistance in
cancer? Oncogene. 37:6195–6211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duan L, Ye L, Zhuang L, Zou X, Liu S,
Zhang Y, Zhang L, Jin C and Huang Y: VEGFC/VEGFR3 axis mediates
TGFß1-induced epithelial-to-mesenchymal transition in non-small
cell lung cancer cells. PLoS One. 13:e02004522018. View Article : Google Scholar
|
|
12
|
Zhang F, Li T, Han L, Qin P, Wu Z, Xu B,
Gao Q and Song Y: TGFß1-induced down-regulation of microRNA-138
contributes to epithelial-mesenchymal transition in primary lung
cancer cells. Biochem Biophys Res Commun. 496:1169–1175. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Delgado-Bellido D, Serrano-Saenz S,
Fernandez-Cortés M and Oliver FJ: Vasculogenic mimicry signaling
revisited: Focus on non-vascular VE-cadherin. Mol Cancer.
16:652017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Q, Yuan Y, Jin Z, Xu T, Gao Y, Wei H,
Li C, Hou W and Hua B: Association between tumor vasculogenic
mimicry and the poor prognosis of gastric cancer in China: An
updated systematic review and meta-analysis. Biomed Res Int.
2016:24086452016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu
D, Yu X and Tian Y: Advanced research on vasculogenic mimicry in
cancer. J Cell Mol Med. 19:315–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang HF, Wang SS, Zheng M, Dai LL, Wang K,
Gao XL, Cao MX, Yu XH, Pang X, Zhang M, et al: Hypoxia promotes
vasculogenic mimicry formation by vascular endothelial growth
factor A mediating epithelial-mesenchymal transition in salivary
adenoid cystic carcinoma. Cell Prolif. 52:e126002019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ou H, Chen Z, Xiang L, Fang Y, Xu Y, Liu
Q, Hu Z, Li X, Huang Y and Yang D: Frizzled 2-induced
epithelial-mesenchymal transition correlates with vasculogenic
mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
Cancer Sci. 110:1169–1182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu T, Sun B, Zhao X, Li Y, Zhao X, Liu Y,
Yao Z, Gu Q, Dong X, Shao B, et al: USP44+ cancer stem cell
subclones contribute to breast cancer aggressiveness by promoting
vasculogenic mimicry. Mol Cancer Ther. 14:2121–2131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q,
Dong X, Yao Z, Li R, Li J, et al: Slug promoted vasculogenic
mimicry in hepatocellular carcinoma. J Cell Mol Med. 17:1038–1047.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding X, Li F and Zhang L: Knockdown of
delta-like 3 restricts lipopolysaccharide-induced inflammation,
migration and invasion of A2058 melanoma cells via blocking
Twist1-mediated epithelial-mesenchymal transition. Life Sci.
226:149–155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X
and Zou Q: TWIST1 and BMI1 in cancer metastasis and
chemoresistance. J Cancer. 7:1074–1080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu QQ, Ma C, Wang Q, Song Y and Lv T: The
role of TWIST1 in epithelial-mesenchymal transition and cancers.
Tumour Biol. 37:185–197. 2016. View Article : Google Scholar
|
|
23
|
Sun T, Sun BC, Zhao XL, Zhao N, Dong XY,
Che N, Yao Z, Ma YM, Gu Q, Zong WK and Liu ZY: Promotion of tumor
cell metastasis and vasculogenic mimicry by way of transcription
coactivation by Bcl-2 and Twist1: A study of hepatocellular
carcinoma. Hepatology. 54:1690–1706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW,
Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional
significance of Twist1 in hepatocellular carcinoma: Its role in
vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar
|
|
25
|
Yochum ZA, Cades J, Wang H, Chatterjee S,
Simons BW, O'Brien JP, Khetarpal SK, Lemtiri-Chlieh G, Myers KV,
Huang EH, et al: Targeting the EMT transcription factor TWIST1
overcomes resistance to EGFR inhibitors in EGFR-mutant
non-small-cell lung cancer. Oncogene. 38:656–670. 2019. View Article : Google Scholar
|
|
26
|
Sun H, Liu T, Zhu D, Dong X, Liu F, Liang
X, Chen C, Shao B, Wang M and Wang Y: HnRNPM and CD44s expression
affects tumor aggressiveness and predicts poor prognosis in breast
cancer with axillary lymph node metastases. Genes Chromosomes
Cancer. 56:598–607. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Sun H, Zhang D, Fan D, Zhang Y,
Dong X, Liu S, Yang Z, Ni C, Li Y, et al: TP53INP1 inhibits
hypoxia-induced vasculogenic mimicry formation via the ROS/snail
signalling axis in breast cancer. J Cell Mol Med. 22:3475–3488.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Chen R, Yang S, Liu W, Li K,
Zhang H, Zhu X and Chen B: Lobaplatin for the treatment of sk-mes-1
lung squamous cell line in vitro and in vivo. OncoTargets Ther.
9:4215–4224. 2016. View Article : Google Scholar
|
|
29
|
Franks TJ and Galvin JR: Sarcomatoid
carcinoma of the lung: Histologic criteria and common lesions in
the differential diagnosis. Arch Pathol Lab Med. 134:49–54.
2010.PubMed/NCBI
|
|
30
|
Dacic S, Finkelstein SD, Sasatomi E,
Swalsky PA and Yousem SA: Molecular pathogenesis of pulmonary
carcinosarcoma as determined by microdissection-based allelotyping.
Am J Surg Pathol. 26:510–516. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Holst VA, Finkelstein S, Colby TV, Myers
JL and Yousem SA: p53 and K-ras mutational genotyping in pulmonary
carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma:
Implications for histogenesis. Am J Surg Pathol. 21:801–811. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao Z, Rahman MA, Chen ZG and Shin DM:
Multiple biological functions of Twist1 in various cancers.
Oncotarget. 8:20380–20393. 2017.PubMed/NCBI
|
|
34
|
Li Y, Sun B, Zhao X, Wang X, Zhang D, Gu Q
and Liu T: MMP-2 and MMP-13 affect vasculogenic mimicry formation
in large cell lung cancer. J Cell Mol Med. 21:3741–3751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hess AR, Seftor EA, Gruman LM, Kinch MS,
Seftor RE and Hendrix MJ: VE-cadherin regulates EphA2 in aggressive
melanoma cells through a novel signaling pathway: Implications for
vasculogenic mimicry. Cancer Biol Ther. 5:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo JQ, Zheng QH, Chen H, Chen L, Xu JB,
Chen MY, Lu D, Wang ZH, Tong HF and Lin S: Ginsenoside Rg3
inhibition of vasculogenic mimicry in pancreatic cancer through
downregulation of VEcadherin/EphA2/MMP9/MMP2 expression. Int J
Oncol. 45:1065–1072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen LX, He YJ, Zhao SZ, Wu JG, Wang JT,
Zhu LM, Lin TT, Sun BC and Li XR: Inhibition of tumor growth and
vasculogenic mimicry by curcumin through downregulation of the
EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer
Biol Ther. 11:229–235. 2011. View Article : Google Scholar
|
|
38
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fan XJ, Wan XB, Yang ZL, Fu XH, Huang Y,
Chen DK, Song SX, Liu Q, Xiao HY, Wang L and Wang JP: Snail
promotes lymph node metastasis and Twist enhances tumor deposit
formation through epithelial-mesenchymal transition in colorectal
cancer. Hum Pathol. 44:173–180. 2013. View Article : Google Scholar
|
